Survival prediction in patients with chronic limbthreatening ischemia who undergo infrainguinal revascularization
Conclusions:

27
These survival prediction models, derived from a large, US cohort of patients who underwent 28 revascularization for CLTI, demonstrated good performance and should be validated. Most CLTI 29 patients considered as candidates for limb salvage were of average perioperative risk, and were 30 predicted to survive beyond 2 years. These models can discriminate patients into low-, medium-,
31
and high-risk groups to facilitate evidence-based revascularization recommendations that are (Table 1) , making evidence-based predictions of survival challenging. While 4 decision-making in the management of CLTI is complex and multifaceted, the most basic step in 5 the decision tree is determining the likelihood that the patient can survive the procedure, and has 6 reasonable life expectancy ahead of him/her. Given the heterogeneity of the disease process and While three large trials are planned or underway throughout the world,(7-9) to date, the applied to discriminate between those with low-, medium-, and high-risk for peri-operative (30-13 day) and 2-year mortality, which may aid in clinical decision-making. VQI is a national cooperative quality improvement initiative developed to prospectively collect 5 data and outcomes for patients undergoing vascular surgical procedures. It is comprised of over 6 3000 physicians from >400 academic and community medical centers across the United States. brachial index and toe-brachial index are collected, they were found to be missing (both limbs) in 10 >40% (n=15714), and therefore these variables were not used in any of the models. Risk groups: We pre-defined high-, medium-, and low-risk groups based on both peri-19 operative and long-term mortality. For each patient, the models were applied to calculate their 20 associated probability of survival at both the 30-day time point, and the 2-year time point; this 21 allowed them to then be assigned into risk groups accordingly. High-risk was defined as 30-day Internal validation of the models included assessment of discrimination and calibration. 
RESULTS
1
Cohort characteristics. Using the VQI database, 38,470 unique patients were identified 2 who underwent infra-inguinal revascularization for CLTI ( Table 2) . Of these, 24,214 underwent 3 PVI (63%), and 14,256 underwent LEB (37%). Revascularization was more commonly 4 performed for tissue loss than for rest pain in both groups (tissue loss: PVI, n=18,104, 75%; 5 LEB, n=8692, 61%). The cohort was predominantly white (n=29,061, 76%), male (n=23,533, 6 61%), and between the ages of 60 and 80 (n=22,135, 58%). While some traditional vascular risk 7 factors were common (70% (n=27,033) were former or current smokers, and 63% (n=24,328) 8 were diabetic), others were less so (31% (n=11,715) had any CAD). The majority (90%) of 9 patients were ambulatory (independent or with assistance); the PVI cohort included more 10 patients who were wheelchair-or bed-bound (11% in the PVI group, versus 6.8% in the LEB 11 group). Notably, 50% of LEB performed were in patients with a prior history of ipsilateral limb 12 revascularization (indication and nature of the pre-VQI procedure unknown). In testing for multicollinearity, the tests for correlation between each of the variables 21 were almost all statistically significant. However, the largest Pearson correlation coefficient was 22 0.36. Since this correlation is considered at the medium range for correlations, we elected to 1 keep these covariates in our final model. Risk groups. Most patients were in the low-risk group (84%); 10% were in the medium-21 risk group, and 6.5% in the high-risk group (Figure 3) . PVI was performed more commonly in 22 all three groups, but the proportion increased as risk increased (low-risk, PVI=59%; medium- Beta coefficients are provided in Tables 3A and 3B ; and samples calculations are 7 provided in Table 5 . Once the 30-day and 2-year probability of survival is calculated for each 8 patient, we used 1 -probability of survival to get probability of mortality. When the 30-day 9 probability of survival >0.97 and 2-year probability of survival >0.70 then patient is considered 10 low risk. If (30-day probability of survival >0.97 and 2-year probability of survival >= 0.50 and 11 2-year probability <=0.7) or (30-day probability of survival <=0.97 but >0.95 and 2-year 12 probability of survival >=0.5) the patient is considered at medium risk. And high risk patients 13 are those with (2-year survival probability <0.5 and any non-missing 30-day probability of 14 survival) or (30-day survival probability <0.95 and any non-missing 2-year probability of 15 survival).
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Of those patients who were "high risk" (n=2176) based on the "30-day survival <95%" 18 criterion, 37% (n=815) also met criteria based on the "2-year survival <50%" criterion. Among 19 those patients who were "low risk" (n=27,952) based on the "30-day survival >97%" criterion,
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100% also met criteria based on the "2-year survival >70%" criterion. When separated out 21 according to risk at the individual time-points (30-day survival risk, and 2-year survival risk 22 groups), the distribution patterns were similar to the distribution of the composite endpoint risk 1 with >80% of patients in the low-risk group, and <10% in the high-risk group.
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Kaplan Meier survival analysis, stratified by risk group demonstrated significant 3 differences when truncated at 2 years (log-rank, p<0.01), and when truncated at 5 years (log-4 rank, p<0.01) (Figure 4) . The 5-year survival estimates were: low-risk 77% (SE=0.004), 5 medium-risk 50% (SE=0.014), and high-risk 43% (SE=0. 017).
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Kaplan Meier survival analysis, stratified by risk group, but dichotomized into "high 7 risk" and "low/medium risk" were significantly different on log-rank analysis (p<0.01) ( and 20% higher than in the PREVENT III study.
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Despite these favorable results in our cohort of CLTI patients, with most patients 1 classified as low-risk (84%), nearly 2/3 of the total cohort were treated using an endovascular 2 approach. These data mirror reports from other large registry studies, likely reflecting compared with 59% in the low-risk group. Notably, the low-risk subgroup (comprising 84% of 7 all patients undergoing infra-inguinal revascularization for CLTI in the VQI database) enjoyed a 8 >75% survival out to five years. Given the significant recrudescence of foot ulcerations and 9 CLTI symptoms, durability of revascularization is likely to be an important consideration for 10 many such patients. worse outcomes. Our model differed from these previous reports in terms of the cohort studied; 1 that is, our study was confined to CLTI patients who underwent vascular interventions, and 2 included both open and endovascular revascularization strategies. The factors we identified were 3 predictive across all three models. In addition, while the risk groups were defined using a 4 composite criterion (a combination of 30-day hazard and 2-year hazard), there was significant 5 overlap -that is, those patients who were high-risk for impaired 30-day survival were typically 6 the same group that were high risk for impaired 2-year survival. And conversely, those with low 7 risk for impaired 30-day survival were the same group that was low risk for impaired 2-year 8 survival. These results, taken together, suggest that identification of these patients can be done without which there cannot be treatment "success," but also addresses limb salvage, which is the 10 surgeon's goal of revascularization. However, these models have not performed particularly well 
